CRISPR-RGEN, TALEN & ZFN
-
TAL Effector Nucleases0,00 €TAL Effector nucleases (TALENs) are artificial restriction enzymes, created by fusing an engineered TAL DNA binding domain (which targets a desired sequences) with the DNA cleavage domain of FokI, a type II restriction enzyme. Learn More
-
Cas9 (dead-double mutant D10A/840A) protein, active440,00 €Cas9 (dead-double mutant D10A/840A) nuclease protein, active, Injection ready, with NLS, 250 µg Learn More
-
Cas9 (dead-double mutant D10A/840A) protein, active255,00 €Cas9 (dead-double mutant D10A/840A) nuclease protein, active, Injection ready, with NLS, 100 µg Learn More
-
Cas9 (dead-double mutant D10A/840A) protein, active175,00 €Cas9 (dead-double mutant D10A/840A) nuclease protein, active, Injection ready, with NLS, 50 µg Learn More
-
Sniper Cas9 protein, active240,00 €Cas9 wild type nuclease protein, active, Injection ready, with NLS, 50 µg Highest specificity amongst all availalble SpCas9 variants without sacrificing on-target activity. Learn More
-
Sniper Cas9 protein, active320,00 €Cas9 wild type nuclease protein, active, Injection ready, with NLS, 100 µg Highest specificity amongst all availalble SpCas9 variants without sacrificing on-target activity. Learn More
-
Sniper Cas9 protein, active630,00 €Cas9 wild type nuclease protein, active, Injection ready, with NLS, 250 µg Highest specificity amongst all availalble SpCas9 variants without sacrificing on-target activity. Learn More
-
Sniper Cas9 protein, active1 495,00 €Cas9 wild type nuclease protein, active, Injection ready, with NLS, 1 mg Highest specificity amongst all availalble SpCas9 variants without sacrificing on-target activity. Learn More
-
Sniper Cas9 protein, active5 240,00 €Cas9 wild type nuclease protein, active, Injection ready, with NLS, 5 mg Highest specificity amongst all availalble SpCas9 variants without sacrificing on-target activity. Learn More
-
Sniper Cas9 protein, active8 390,00 €Cas9 wild type nuclease protein, active, Injection ready, with NLS, 10 mg Highest specificity amongst all availalble SpCas9 variants without sacrificing on-target activity. Learn More